Jacques Dutrieux

Jacques Dutrieux

Auto-generated profile, based on publicly available information

Jacques Dutrieux

Université Paris Cité, CNRS, INSERM, Institut Cochin, F-75014 Paris, France

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2015 in Retrovirology
Verified
Journal Article
Open access
PDF file
JDJacques Dutrieux
Jacques Dutrieux
DPDébora M Portilho
Débora M Portilho
NANathalie Arhel
Nathalie Arhel
UHUriel Hazan
Uriel Hazan
Sebastien NisoleSebastien Nisole
Sebastien Nisole
The TRIM5α restriction factor interferes with retroviral infections by inhibiting an early step of viral replication. TRIM5α activity was recently proposed to be regulated by the SUMO machinery and one SUMO consensus conjugation site as well as three putative SUMO interacting motifs (SIMs) were identified within TRIM5α sequence. Whereas mutation of the SIM sequences was found to abolish TRIM5α antiviral activity, mutation of the consensus SUMO conjugation site did not affect its restriction capacity, although this putative site has never been shown to be actually a SUMO substrate. Here we further demonstrate that TRIM5α relies on the SUMO machinery to promote restriction, since SUMO1 overexpression enhances TRIM5α-mediated retroviral inhibition whereas knockdown of SUMO1 or E2 SUMO conjugating enzyme Ubc9 prevents restriction. Furthermore, we show for the first time that TRIM5α is SUMOylated both in vitro and in cellulo and that Lysine 10 is the main SUMOylation site. Mutation of the consensus SUMO conjugation motif in position 10 abrogated SUMOylation at this position, but did not disrupt TRIM5α antiviral activity. Altogether, our results confirm that the SUMO machinery is involved in TRIM5α-mediated retroviral restriction, and demonstrate that TRIM5α is a SUMO 1 and SUMO 2 substrate. The inability to abrogate TRIM5α antiviral activity by mutating its main SUMO conjugation motif supports the notion that non-covalent interaction with SUMO or SUMOylated proteins rather than TRIM5α direct SUMOylation is required.

30 August 2023 in Cancer Immunology Research
Verified
Journal Article
Closed access
PDF file
MMMaude Marchais
Maude Marchais
LSLuca Simula
Luca Simula
MPMélanie Phayanouvong
Mélanie Phayanouvong
FMFathia Mami-Chouaib
Fathia Mami-Chouaib
GBGeorges Bismuth
Georges Bismuth
MMMarianne Mangeney
Marianne Mangeney
Chimeric antigen receptor (CAR) T cells have shown promising results in the treatment of B-cell malignancies. Despite the successes, challenges remain. One of them directly involves the CAR T-cell manufacturing process and especially the ex vivo activation phase. While this is required to allow infection and expansion, ex vivo activation dampens the antitumor potential of CAR T cells. Optimizing the nature of the T cells harboring the CAR is a strategy to address this obstacle and has the potential to improve CAR T-cell therapy, including for solid tumors. Here, we describe a protocol to create CAR T cells without ex vivo preactivation by inhibiting the transcription factor FOXO1 (CAR TAS cells). This approach made T cells directly permissive to lentiviral infection, allowing CAR expression, with enhanced antitumor functions. FOXO1 inhibition in primary T cells (TAS cells) correlated with acquisition of a stem cell memory phenotype, high levels of granzyme B, and increased production of TNFα. TAS cells displayed enhanced proliferative and cytotoxic capacities as well as improved migratory properties. In vivo experiments showed that CAR TAS cells were more efficient at controlling solid tumor growth than classical CAR T cells. The production of CAR TAS from patients’ cells confirmed the feasibility of the protocol in clinic.

22 September 2023 in Science Advances
Verified
Journal Article
Open access
HRHélène M. Roux
Hélène M. Roux
AMAmira Marouf
Amira Marouf
JDJacques Dutrieux
Jacques Dutrieux
BMBénédicte Charmeteau-De Muylder
Bénédicte Charmeteau-De Muylder
SFSuzanne Figueiredo-Morgado
Suzanne Figueiredo-Morgado
RCRémi Cheynier
Rémi Cheynier
Thymic activation improves the outcome of COVID-19 patients with severe pneumonia. The rs2204985 genetic polymorphism within the TCRA-TCRD locus, which affects thymic output in healthy individuals, was found here to modify SARS-CoV-2–specific immunity and disease severity in COVID-19 patients with severe pneumonia. Forty patients with severe COVID-19 pneumonia were investigated. The GG genotype at the rs2204985 locus was associated, independently of age and sex, with stronger and long-lasting anti–SARS-CoV-2 helper and cytotoxic T cell responses 6 months after recovery. The GG genotype was also associated with less severe lung involvement, higher thymic production, and higher counts of blood naïve T lymphocytes, including recent thymic emigrants, and a larger population of activated stem cell memory CD4 + T cells. Overall, GG patients developed a more robust and sustained immunity to SARS-CoV-2. Polymorphism at rs2204985 locus should be considered as an additional predictive marker of anti–SARS-CoV-2 immune response.

5 April 2023 in Cell Reports Methods
Verified
Journal Article
Open access
HRHélène Marie Roux
Hélène Marie Roux
SFSuzanne Figueiredo
Suzanne Figueiredo
LSLucas Sareoua
Lucas Sareoua
MSMaud Salmona
Maud Salmona
JHJuliette Hamroune
Juliette Hamroune
JDJacques Dutrieux
Jacques Dutrieux
Unintegrated HIV DNA represents between 20% and 35% of the total viral DNA in infected patients. Only the linear forms (unintegrated linear DNAs [ULDs]) can be substrates for integration and for the completion of a full viral cycle. In quiescent cells, these ULDs may be responsible for pre-integrative latency. However, their detection remains difficult due to the lack of specificity and sensitivity of existing techniques. We developed an ultra-sensitive, specific, and high-throughput technology for ULD quantification called DUSQ (DNA ultra-sensitive quantification) combining linker-mediated PCR and next-generation sequencing (NGS) using molecular barcodes. Studying cells with different activity levels, we determined that the ULD half-life goes up to 11 days in resting CD4+ T cells. Finally, we were able to quantify ULDs in samples from patients infected with HIV-1, providing a proof of concept for the use of DUSQ in vivo to track pre-integrative latency. DUSQ can be adapted to the detection of other rare DNA molecules.

31 October 2025 in EMBO Reports
Verified
Journal Article
Open access
MPMarjory Palaric
Marjory Palaric
MVMargaux Versapuech
Margaux Versapuech
DJDelphine Judith
Delphine Judith
CACorentin Aubé
Corentin Aubé
MLMarjorie Leduc
Marjorie Leduc
CBClarisse Berlioz-Torrent
Clarisse Berlioz-Torrent
In addition to their role in canonical autophagy, autophagy proteins (ATG) contribute to various cellular processes, including phagocytosis, membrane remodeling, and vesicle secretion. Several viruses also exploit components of the autophagy pathway for their own replication. Here, we explore the role of ATG proteins in HIV-1 assembly. Postulating that host proteins crucial for virion assembly are present at the assembly site and can be incorporated within virions, we analyze the proteome of HIV-1 preparations using mass spectrometry. We identify an enrichment of macroautophagy-related terms, notably 3 of the 6 ATG8 (LC3/GABARAP) proteins. Functional studies reveal that GABARAP proteins are critical for the production of infectious virions. Knockout of GABARAP proteins reduces the packaging of viral genomic RNA (gRNA) into particles, impairing virion infectivity. GABARAPL1 associates with gRNA and interacts with Gag in an RNA-dependent manner. Additionally, GABARAP knockout increases cellular Gag:gRNA complexes and decreases gRNA association with membranes, suggesting that GABARAP proteins regulate gRNA fate during HIV-1 assembly by facilitating its packaging. This study uncovers a novel role for GABARAP proteins in HIV-1 genome packaging.

1 October 2020 in Antiviral Research
Verified
Journal Article
Closed access
MSMaud Salmona
Maud Salmona
LFLinda Feghoul
Linda Feghoul
SMSéverine Mercier-Delarue
Séverine Mercier-Delarue
EDElise Diaz
Elise Diaz
MSMarion Splitberger
Marion Splitberger
JLJérôme LeGoff
Jérôme LeGoff